19 October, 2005

Biodefense

Here's an interesting item from the NTI's Global Security Newswire. Apparently clinical (nonhuman) testing has proven positive for "antisense technology" that reduces the lethality of Anthrax, Marburg, or Ricin. It appears to be gene-specific, not a universal "magic bullet," but this could have some interesting defense applications.

No comments: